Skip to main content
Loading

Designing mRNA to induce an increasingly robust immune response

30 Oct 2024
Oligonucleotide Discovery
  • Optimizing mRNA Stability and Translation Efficiency
  • Targeted Delivery and Uptake by Immune Cells
  • Balancing Immune Activation and Safety
Industry Experts
Ravinder Earla, Associate Director - Aviceda Therapeutics